From January 1, 2024 to March 18, 2024, the company has repurchased 245,800 shares, representing 0.55% for ¥803.39 million. With this, the company has completed the repurchase of 1,909,900 shares, representing 4.18% for ¥5,999.99 million under the buyback announced on May 8, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3,655 JPY | +1.67% | +1.95% | +18.28% |
Mar. 20 | Kissei Pharmaceutical Completes 6 Billion Yen Buyback Program | MT |
Mar. 19 | Tranche Update on Kissei Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 8, 2023. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.28% | 1.06B | |
+5.48% | 71.19B | |
+12.55% | 9.3B | |
-13.75% | 5.01B | |
+42.38% | 4.47B | |
+4.51% | 3.96B | |
+21.10% | 2.44B | |
-19.05% | 2.41B | |
-28.72% | 2.23B | |
+11.13% | 2.02B |
- Stock Market
- Equities
- 4547 Stock
- News Kissei Pharmaceutical Co., Ltd.
- Tranche Update on Kissei Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 8, 2023.